Alvin S. Tan

Selwyn Street And Pembroke Street, 
Hamilton, WKO, NZ 
Selwyn Street And Pembroke Street, 
Hamilton, WKO, NZ 

Overview

Alvin Tan practices practicing medicine in Hamilton, New Zealand.

His clinical expertise encompasses Glioblastoma, Astrocytoma, Prostate Cancer, and Testicular Cancer.

He is actively involved in clinical research, co-authoring 20 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Selwyn Street And Pembroke Street, Hamilton, WKO 3204, New Zealand

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Randomised Phase 3 Trial of Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer: ENZAMET
Randomised Phase 3 Trial of Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer: ENZAMET
Enrollment Status: Active_not_recruiting
Publish Date: February 06, 2025
Intervention Type: Drug
Study Drugs: Enzalutamide, Non-Steroidal Anti Androgen, Luteinizing Hormone Releasing Hormone Analog or Surgical Castration
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial Comparing CB-839 in Combination With Cabozantinib (CB-Cabo) vs. Placebo With Cabozantinib (Pbo-Cabo) in Patients With Advanced or Metastatic Renal Cell Carcinoma (RCC)
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial Comparing CB-839 in Combination With Cabozantinib (CB-Cabo) vs. Placebo With Cabozantinib (Pbo-Cabo) in Patients With Advanced or Metastatic Renal Cell Carcinoma (RCC)
Enrollment Status: Completed
Publish Date: March 20, 2023
Intervention Type: Drug
Study Drugs: CB-839, Cabozantinib
Study Phase: Phase 2
View 1 Less Clinical Trial

20 Total Publications

Intensive multimodal ketogenic metabolic therapy in glioblastoma: A clinical trial.
Intensive multimodal ketogenic metabolic therapy in glioblastoma: A clinical trial.
Journal: Neuro-oncology advances
Published: April 14, 2026

Frequently Asked Questions about Alvin S. Tan

Is Alvin S. Tan a top-rated expert for Glioblastoma?

MediFind is an objective health platform that identifies experts based on real-world data. Alvin S. Tan is classified as an Experienced expert for Glioblastoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Alvin S. Tan participate in research or clinical trials?

Yes. Alvin S. Tan has published 20 articles and abstracts on conditions like Glioblastoma. You can view a list of Alvin S. Tan's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Tan's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile